SNWV vs. MDXG, INMD, TNDM, BBNX, IRMD, CLPT, EMBC, AXGN, SIBN, and BFLY
Should you be buying Sanuwave Health stock or one of its competitors? The main competitors of Sanuwave Health include MiMedx Group (MDXG), InMode (INMD), Tandem Diabetes Care (TNDM), Beta Bionics (BBNX), iRadimed (IRMD), ClearPoint Neuro (CLPT), Embecta (EMBC), AxoGen (AXGN), SiBone (SIBN), and Butterfly Network (BFLY). These companies are all part of the "medical equipment" industry.
Sanuwave Health vs. Its Competitors
Sanuwave Health (NASDAQ:SNWV) and MiMedx Group (NASDAQ:MDXG) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, media sentiment, institutional ownership, profitability, analyst recommendations, valuation and dividends.
In the previous week, Sanuwave Health had 20 more articles in the media than MiMedx Group. MarketBeat recorded 23 mentions for Sanuwave Health and 3 mentions for MiMedx Group. MiMedx Group's average media sentiment score of 0.83 beat Sanuwave Health's score of -0.17 indicating that MiMedx Group is being referred to more favorably in the news media.
MiMedx Group has a net margin of 8.84% compared to Sanuwave Health's net margin of -97.03%. MiMedx Group's return on equity of 23.03% beat Sanuwave Health's return on equity.
MiMedx Group has higher revenue and earnings than Sanuwave Health. Sanuwave Health is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks.
42.5% of Sanuwave Health shares are owned by institutional investors. Comparatively, 79.2% of MiMedx Group shares are owned by institutional investors. 14.9% of Sanuwave Health shares are owned by company insiders. Comparatively, 1.7% of MiMedx Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Sanuwave Health currently has a consensus price target of $54.00, indicating a potential upside of 71.59%. MiMedx Group has a consensus price target of $12.00, indicating a potential upside of 82.37%. Given MiMedx Group's higher probable upside, analysts clearly believe MiMedx Group is more favorable than Sanuwave Health.
Sanuwave Health has a beta of 1.33, indicating that its stock price is 33% more volatile than the S&P 500. Comparatively, MiMedx Group has a beta of 1.73, indicating that its stock price is 73% more volatile than the S&P 500.
Summary
MiMedx Group beats Sanuwave Health on 11 of the 17 factors compared between the two stocks.
Get Sanuwave Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for SNWV and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding SNWV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Sanuwave Health Competitors List
Related Companies and Tools
This page (NASDAQ:SNWV) was last updated on 10/15/2025 by MarketBeat.com Staff
